Alzheimer’s drug lowers mortality
December 7, 2012Sales and Marketing Alzheimer's, Janssen, Razadyne, Roche, lilly
A study of Janssen Pharmaceuticals’ Razadyne suggests that the Alzheimer’s drug helped patients stay alive longer and slowed their cognitive …
Add value, pharma urged
December 7, 2012Medical Communications, Sales and Marketing ABPI, CCGs, NHS, Pharmafocus, Prescriber
Pharma will only form lasting relationships with the NHS in future by demonstrating its value, according to Kevin Blakemore, NHS …
Working Life: Caroline Horwood
December 6, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Working Life
How did you find your way into your current role?Through an exciting and challenging route over 25 years! The key …
Circassia appoints new head to its Board of directors
December 6, 2012Manufacturing and Production, Research and Development, Sales and Marketing Circassia
Speciality biopharma firm Circassia has announced the appointment of Dr Jean-Jacques Garaud to its Board of directors. Garaud has extensive …
Protein Sciences builds flu vaccine facility
December 6, 2012Manufacturing and Production FDA, Protein
US drugmaker Protein Sciences has taken over a manufacturing facility formerly owned by Pfizer’s Wyeth unit as it prepares for …
‘Open door’ for pharma
December 6, 2012Sales and Marketing CCGs, NHS, NICE, Pharmafocus, Prescriber, UK
The NHS’s new clinical commissioning groups (CCGs) will be more welcoming to approaches from pharma than the old PCTs were, …
‘Risk share’ with us, say CCGs
December 6, 2012Sales and Marketing CCGs, NHS, Pharmafocus, Prescriber, pharma
Pharma companies have been urged to “put your head on the block” by coming up with risk-sharing funding plans for …
uniQure appoints Basilea’s chief commercial officer
December 6, 2012Manufacturing and Production, Research and Development, Sales and Marketing Basilea, uniQure
Dutch human gene therapy firm uniQure has appointed Hans Christian Rohde as chief commercial officer. Rohde joins uniQure from Basilea …
ImmunoCellular appoints Andrew Gengos as chief executive
December 5, 2012Manufacturing and Production, Research and Development, Sales and Marketing Gengos, ImmunoCellular
Clinical stage firm ImmunoCellular Therapeutics has announced the appointment of Andrew Gengos as president and chief executive and member of …
New boost for drug candidates
December 5, 2012Research and Development, Sales and Marketing Bayer, EFPIA, K4DD, Leiden
A new project is trying to increase the hit rates of successful drug candidates by improving the way they are …
Trajenta may reduce stroke damage
December 4, 2012Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin
Boehringer Ingelheim’s diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …
Excipient certification project moves forward
December 4, 2012Manufacturing and Production DEG, EXCiPACT, GDP, GMP
The EXCiPACT certification scheme for pharmaceutical excipients has taken a step closer to fruition with agreements now in place with …
R&D costs rise ten-fold
December 4, 2012Research and Development, Sales and Marketing OHE, R&D, research and development
Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …
NHS ‘entering treacherous waters’
December 3, 2012Sales and Marketing Ham, NHS, coalition, king's fund, reforms
A leading think tank has marked the coalition government’s health policy with what amounts to a C+ in its mid-term …
J&J’s Alex Gorsky to be chairman and chief executive
December 3, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Johnson & Johnson has has elected its chief executive Alex Gorsky to be its chairman of the Board of directors. …
Pharmacos ink green manufacturing pact with EU academics
December 3, 2012Manufacturing and Production Bayer, EU, Pharmacos, Sanofi
A group of top pharma multinationals have set up a public-private partnership dedicated to the development of manufacturing sustainable pharmaceuticals …
Janssen eases HIV patent burden
December 3, 2012Sales and Marketing AIDS, Janssen, Prezista, darunavir
In a move which should appeal to public health campaigners, Janssen has declared that it will not enforce patents for …
Help CCGs help you, pharma told
November 30, 2012Medical Communications, Sales and Marketing CCGs, JSNA, NHS, pharma
Pharma companies have a big opportunity to take advantage of the changes in the structure of the NHS, according to …
Ranbaxy suspends atorvastatin manufacturing after recall
November 30, 2012Manufacturing and Production FDA, Ranbaxy, atorvastatin, recall
Ranbaxy Laboratories has called a halt to manufacturing its generic atorvastatin product until it can get to the bottom of …
New chief executive for Cipla
November 30, 2012Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena
Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
